Searched over 200M research papers for "rhd cardiac"
10 papers analyzed
These studies suggest that echocardiographic screening, advances in diagnosis and treatment, and integrating care models are crucial in managing rheumatic heart disease, particularly in low-resource settings.
20 papers analyzed
Rheumatic heart disease (RHD) remains a significant cause of cardiac morbidity and mortality, particularly in children and adolescents from developing countries. Echocardiogram-based screening has proven to be a sensitive method for early detection of RHD. A systematic review and meta-analysis revealed that the prevalence of echocardiography-detected RHD in endemic regions is approximately 23 per 1,000 individuals, with definitive RHD cases at 9 per 1,000 individuals. This prevalence varies slightly across different continents, with Africa, Oceania, Asia, and Latin America showing similar rates.
In resource-poor settings, focused cardiac ultrasound (FCU) has emerged as a feasible alternative for RHD screening. Studies have shown that non-expert staff using pocket-sized echocardiography machines can achieve acceptable sensitivity and specificity for RHD detection, making it a viable option for mass screening. This approach could significantly enhance early diagnosis and intervention efforts in low-resource environments.
RHD is a chronic condition resulting from repeated episodes of acute rheumatic fever (ARF), an autoimmune response to group A Streptococcus infections. The disease primarily affects the heart valves, leading to long-term damage and significant morbidity and mortality in resource-poor settings. Despite advances in understanding the disease's pathogenesis, diagnostic approaches remain largely unchanged, relying on clinical features and the Jones Criteria.
Recent genetic studies have identified specific loci associated with RHD susceptibility, particularly in Black African populations. A genome-wide association study (GWAS) revealed a novel risk locus at 11q24.1, highlighting the importance of genetic factors in RHD development. Understanding these genetic predispositions could aid in developing targeted prevention and intervention strategies.
While echocardiography has improved the sensitivity of RHD screening, concerns about its specificity and the interpretation of minor abnormalities persist. The natural history of subclinical RHD detected through echocardiographic screening remains unclear, necessitating long-term follow-up studies to determine the significance of early detection. Additionally, for screening programs to be effective, improvements in secondary prophylaxis delivery systems are essential.
Innovative approaches, such as using machine learning for automated RHD screening based on phonocardiograms, show promise. These methods can be deployed by non-medically trained individuals, offering a cost-effective and scalable solution for early detection in developing countries. Such tools could complement existing screening programs and enhance early intervention efforts.
Rheumatic heart disease continues to pose a significant public health challenge, particularly in low-income settings. Advances in echocardiographic screening and the development of focused cardiac ultrasound approaches offer hope for early detection and intervention. However, challenges related to specificity, interpretation, and the need for improved secondary prophylaxis systems remain. Genetic studies and innovative screening technologies hold potential for more effective prevention and management of RHD, ultimately reducing its global burden.
Most relevant research papers on this topic